Apixaban 5 mg ‘appropriate’ in AF patients with one dose-reduction criterion

The benefits of apixaban 5 mg over warfarin are maintained in patients with atrial fibrillation who are of advanced age, have low body weight or elevated creatinine levels, analysis of ARISTOTLE data shows.
Source: MedWire News - Category: Consumer Health News Tags: Arrhythmia Source Type: news